Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.55 |
| ▸ | MAOB | P27338 | 7/20 | 0.53 |
| ▸ | DAO | P14920 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL29202239 | 0.98 | TAAR1 (0.53) | TAAR1MAOBDAOKIF11 | |
| Iodide SCHEMBL29202228 | 0.98 | TAAR1 (0.53) | TAAR1MAOBDAOKIF11 | |
| Hydrochloric Acid SCHEMBL2445996 | 0.98 | MAOB (0.56) | TAAR1MAOB | |
| SCHEMBL5560530 | 0.89 | MAOB (0.69) | MAOB | |
| SCHEMBL2024806 | 0.88 | SLC7A5 (0.48) | TAAR1MAOBDAOKIF11 | |
| Acetic Acid SCHEMBL29202197 | 0.88 | DHODH (0.51) | TAAR1MAOB | |
| SCHEMBL8321773 | 0.86 | SLC7A5 (0.50) | MAOBDAOKIF11 | |
| SCHEMBL5185022 | 0.85 | LTA4H (0.49) | — | |
| SCHEMBL2097292 | 0.85 | SLC7A5 (0.49) | MAOBDAOKIF11 | |
| SCHEMBL6230413 | 0.85 | SLC7A5 (0.49) | MAOBDAOKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371337-A | Metal halide perovskite nanocrystalline resistant to heat-induced fluorescence quenching, and preparation method and application thereof | 华南理工大学 | 2025-01-28 | — | — | CN | claimed |
| CN-117043140-A | Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidal active substances | 拜耳公司 | 2023-11-10 | — | — | CN | claimed |
| EP-1219591-B1 | Process for preparing 2-(4-trifluoromethoxyphenyl)ethylamine | BAYER CHEMICALS AG (DE) | 2004-03-31 | — | — | EP | claimed |
| US-6441239-B1 | Process for preparing 2-(4-trifluoromethoxyphenyl)ethylamine and 4-bromomethyl-and 4-chloromethyl-1-trifluoromethoxybenzene | BAYER AKTIENGESELLSCHAFT (DE) | 2002-08-27 | — | — | US | claimed |
| EP-1219591-A1 | Process for preparing 2-(4-trifluoromethoxyphenyl)ethylamine and 4-bromomethyl- and 4-chloromethyl- -1trifluoromethoxybenzene | Bayer Aktiengesellschaft (DE) | 2002-07-03 | — | — | EP | claimed |
| US-20020082454-A1 | PROCESS FOR PREPARING 2-(4-TRIFLUOROMETHOXYPHENYL)ETHYLAMINE AND 4-BROMOMETHYL-AND 4-CHLOROMETHYL-1-TRIFLUOROMETHOXYBENZENE | LANXESS DEUTSCHLAND GMBH (DE) | 2002-06-27 | — | — | US | claimed |
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DISCOVERY PARTNERS INTERNATIONAL, INC. | 2002-05-16 | — | — | US | claimed |
| US-20250144094-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ERASCA, INC. | 2025-05-08 | — | — | US | disclosed |
| WO-2025054339-A1 | TRIAZOLOPYRIDINE COMPOUNDS AS INHIBITORS OF KIT | ARCUS BIOSCIENCES, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| CN-119371337-A | Metal halide perovskite nanocrystalline resistant to heat-induced fluorescence quenching, and preparation method and application thereof | 华南理工大学 | 2025-01-28 | — | — | CN | disclosed |
| CN-119072141-A | Long-life perovskite light-emitting diode and preparation method thereof | 南京工业大学 | 2024-12-03 | — | — | CN | disclosed |
| EP-4433059-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | Erasca, Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| CN-117682967-A | Inhibitor for targeting c-Myc and application thereof | 四川大学 | 2024-03-12 | — | — | CN | disclosed |
| EP-0981516-A1 | SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D?3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 2000-03-01 | — | — | EP | disclosed |
| EP-0922035-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | SMITHKLINE BEECHAM PLC (GB) | 1999-06-16 | — | — | EP | disclosed |
| WO-1998049145-A1 | SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998006699-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | SMITHKLINE BEECHAM PLC (GB) | 1998-02-19 | — | — | WO | disclosed |
| EP-0665225-B1 | 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same | UBE INDUSTRIES (JP) | 1996-11-27 | — | — | EP | disclosed |
| US-5498612-A | INSECTICIDE, ACARICIDE, FUNGICIDE, NEMATOCIDE | UBE INDUSTRIES, LTD. (JP) | 1996-03-12 | — | — | US | disclosed |
| EP-0665225-A1 | 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same | UBE INDUSTRIES, LTD. (JP) | 1995-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144094-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ULK1, ULK2, ULK3 | TAAR1 4124/4885MAOB 4469/4885DAO 4525/4885 |
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DNPEP, LNPEP, NPEPPS | TAAR1 1082/4885MAOB 1190/4885DAO 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.